PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 69 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,000 | 0.0% | 2,990 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 2,990 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 2,990 | -7.7% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 3,240 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | -98.8% | 3,240 | -98.3% | 0.00% | – |
Q1 2016 | $81,000 | +8.0% | 193,035 | +203.7% | 0.00% | – |
Q4 2015 | $75,000 | +2400.0% | 63,558 | +1841.9% | 0.00% | – |
Q3 2015 | $3,000 | -62.5% | 3,273 | -46.9% | 0.00% | – |
Q2 2015 | $8,000 | -73.3% | 6,164 | -72.2% | 0.00% | – |
Q1 2015 | $30,000 | -34.8% | 22,212 | -32.4% | 0.00% | – |
Q4 2014 | $46,000 | +283.3% | 32,862 | +276.8% | 0.00% | – |
Q3 2014 | $12,000 | -33.3% | 8,722 | -7.4% | 0.00% | – |
Q2 2014 | $18,000 | -68.4% | 9,418 | -68.5% | 0.00% | – |
Q1 2014 | $57,000 | -52.5% | 29,863 | -65.4% | 0.00% | – |
Q4 2013 | $120,000 | +2900.0% | 86,304 | +2663.5% | 0.00% | – |
Q3 2013 | $4,000 | 0.0% | 3,123 | +2.1% | 0.00% | – |
Q2 2013 | $4,000 | – | 3,059 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |